CW
DXCM icon

Curio Wealth’s DexCom DXCM Stock Holding History

Curio Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$63 – 380
2026
Q1 		$63 Buy
+1
New +$70 ﹤0.01% 1085

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Curio Wealth's DXCM Position: Q2 2026 in Review

Curio Wealth sold out of DexCom (DXCM) in Q2 2026, closing a stake of 1 share — an estimated $63 sold.

Curio Wealth first reported a position in DXCM in Q1 2026 and held it in 1 quarter. The position peaked at $63 in Q1 2026. 971 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Curio Wealth reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Curio Wealth sold 1 DexCom share in Q2 2026, an estimated $63.
  • Curio Wealth first reported a position in DexCom in Q1 2026 and held it in 1 quarter.
  • Curio Wealth's DexCom position peaked at $63 in Q1 2026.
  • 971 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.